DysKalc

DysKalc was created to help neurologists in decision-making process regarding therapeutic management of Parkinson’s disease, aiming to a more personalized approach. The clinician can estimate the actual odds of a patient using levodopa to develop dyskinesias in every consultation. Calculated predicted probability of each evaluation is stratified in 2 groups: low and high probability, based on a specific cut-off. Therapeutic management recommendations are suggested according to the calculated predicted probability.